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We describe the case of a 25 year-old woman at 27 weeks of 
gestation who was admitted to our intensive care unit (ICU) 
for acute respiratory distress syndrome (ARDS) caused by 
pandemic 2009 H1N1 influenza A. She presented with sep-
tic shock and refractory hypoxemia unresponsive to rescue 
therapies such as recruitment maneuvers, prone positioning, 
and nitric oxide inhalation. Extracorporeal membrane oxy-
genation (ECMO) for respiratory support was instituted, and 
the patient’s clinical conditions progressively improved: she 
was extubated after 16 days and discharged from the ICU 3 
days later. No fetal complications were observed. At 38 weeks 
of gestation she gave birth to a healthy baby. ASAIO Journal 
2012; 58:281–284.
Treatment of acute respiratory distress syndrome (ARDS) in 
pregnant women is particularly challenging because of the 
high risk of death for both the mother and the fetus. In cases of 
refractory impairment of gas exchanges unresponsive to con-
ventional measures, extracorporeal membrane oxygenation 
(ECMO) can be a life-saving maneuver, but it is a very demand-
ing and complex technique. The clinical management of these 
cases is extremely challenging and has to be made in conjunc-
tion with the obstetric, neonatal, and critical care teams.
Case Description
Two days after returning from a trip to Morocco, a 25 year-
old primigravida at 27 weeks of gestation presented to the 
emergency department with fever and dyspnea. History and 
physical examination were unremarkable (in particular, the 
body mass index was within normal limits, and there was no 
history of asthma, diabetes, immunosuppression, or cardiac 
diseases), and her prenatal course was normal. She was febrile 
and hypotensive (blood pressure [BP] 85/40), oxygen satura-
tion was 86% while breathing 100% oxygen, and a chest x-ray 
showed a left lung infiltrate. She was admitted to the intensive 
care unit (ICu) with a presumptive diagnosis of community-
acquired pneumonia, and therapy with ceftriaxone (Fidia Far-
maceutici, Abano Terme, Italy) and azythromycin (Pfizer Italia, 
Latina, Italy) was started. Blood gas analysis at arrival (with an 
inspired oxygen fraction of 100%) showed severe hypoxemia 
and mixed acidosis (pH 7.24, pO2 59.2, pCO2 48, base excess 
−7, HCO3 19.8, lactate 1.2). A chest x-ray showed extensive, 
bilateral infiltrates (Figure 1). She was intubated and ventilated 
with a tidal volume (TV) of 6 ml/kg ideal body weight, a respi-
ratory rate (RR) of 40, and a positive end-expiratory pressure 
(PEEP) of 20 cm H2O; plateau pressure (Pplat) was 37 cm H2O, 
and respiratory system compliance (Cpl, rs) was 17 ml/cm 
H2O. Recruitment maneuvers (pressure-controlled inﬂations of 
40 and 45 cm H2O sustained for 20 sec) and nitric oxide inha-
lation (up to 20 ppm) failed to obtain any improvement in gas 
exchanges. Despite the state of pregnancy, prone positioning 
was attempted without significant benefit on arterial oxygen-
ation. Obstetric ultrasonography showed a normal fetal growth 
and biophysical profile; notably, no adverse effects on fetus 
vitality were observed during the prone positioning trial.
Bacterial cultures of blood, urine, and tracheal aspirate were 
negative, although a nasal swab was positive for pandemic 
2009 H1N1 infection (assessed with reverse transcription 
polymerase chain reaction [rt-PCR]). Treatment with high-dose 
oseltamivir (Roche, Milano, Italy) (300 mg/day by nasogastric 
tube) was started; a complete course of dexamethasone (Hos-
pira Italia, Napoli, Italy) was administered to promote fetal 
lung development.
One day after admission the patient remained severely 
hypoxemic, and a chest x-ray showed signs of barotrauma 
(subcutaneous emphysema and basal left pneumothorax): for 
these reasons, we decided to initiate an extracorporeal respira-
tory support by means of a venovenous bypass.
A 25 F drainage cannula was placed in the right femoral 
vein, and a 19 F return cannula was placed into the right 
internal jugular vein. Vessels were cannulated percutane-
ously as previously described.1 Blood was drained from 
the inferior vena cava and propelled by a centrifugal pump 
(Jostra Rotaﬂow, Maquet Cardiopulmonary AG, Hechingen, 
Germany) through an artificial lung (PLS Quadrox, Maquet 
Cardiopulmonary AG). Extracorporeal blood ﬂow was set 
to 3.5 L/min and sweep gas ﬂow to 4 L/min of oxygen: 
the gradual correction of hypercapnia and acidosis (pCO2 
from 52.9 to 41 and pH from 7.29 to 7.39 over a period of 
30 min) allowed a marked reduction of TV (from 350 to 
250 ml), RR (from 40 to 10/min), and Pplat (from 37 to 30 cm 
H2O), whereas a high PEEP (20 cm H2O) was maintained to 
avoid excessive reduction of mean airway pressure (Paw) and 
consequent lung collapse or pulmonary ﬂooding; despite 
the maintenance of relatively high Paw, the reduction of 
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inspiratory pressures and minute ventilation avoided wors-
ening of air leak, and no chest drainage was required.
Anticoagulation was maintained with infusion of unfrac-
tionated heparin titrated to an activated clotting time of 
180–220 sec; no thrombotic or hemorrhagic complications 
were observed.
Cardiotocography was performed three times a day to assess 
fetal well-being and showed periods of low variability of fetal 
heart rate: sonography for biophysical profile and umbilical 
and middle cerebral artery Doppler evaluation remained nor-
mal, indicating that the reduced variability of fetal heart rate 
was a consequence of pharmacologic sedation. After ECMO 
institution the patient’s clinical conditions gradually improved 
(Figure 2), and the extracorporeal support was withheld after 13 
days. The patient was then rapidly weaned from the ventilator 
and extubated 16 days after admission. Pregnancy proceeded 
regularly until 38.2 weeks of gestation, when the patient deliv-
ered vaginally a healthy baby.
Discussion
In March 2009, an outbreak of respiratory illness caused by 
a novel, swine-origin inﬂuenza A H1N1 virus was identified in 
Mexico2; thereafter, the disease spread all over the world and 
as of April 2010 at least 17,853 deaths were reported to the 
World Health Organization (WHO).
Pregnancy has been recognized as an important risk factor for 
respiratory complications of pandemic H1N1 inﬂuenza, together 
with obesity, asthma, diabetes, and immunosuppression.3
The clinical presentation of pandemic H1N1 inﬂuenza 
during pregnancy is similar to that observed in the general 
population. In most cases the disease presents as a mild illness, 
but some patients develop refractory hypoxemia, frequently 
associated with shock and multiple organ failure.3 Hypoxemia 
usually requires invasive mechanical ventilation with high 
PEEP and is unresponsive to rescue therapies such as prone 
positioning and nitric oxide inhalation.4 In the most severe 
patients ECMO has been used as salvage therapy, with the aim 
of maintaining acceptable gas exchanges while limiting the 
risk of ventilator-induced lung injury.5,6
Experience with ECMO in pregnancy is limited. Before the 
inﬂuenza pandemic, ECMO had been described only in a few 
obstetric patients with ARDS from different causes. In a review 
of these cases, Cunningham et al.7 observed that maternal and 
fetal outcomes were better in patients ventilated for less than 7 
days before ECMO institution, similar to what was observed in 
the general adult population.
The information about the use of ECMO in pregnant patients 
with 2009 H1N1 inﬂuenza is scarce. In the ANZIC group 
experience,8 9 of the 64 (14%) critically ill pregnant women 
received ECMO, and 6 of them (67%) survived. Very recently, 
authors from the same Australian group analyzed retrospec-
tively the clinical course of 12 pregnant or postpartum women 
treated with ECMO in seven tertiary centers. They reported a 
high rate of hemorrhagic complications that caused the death 
of three women, whereas ECMO circuit-related complications 
were rare; 66% of these patients survived, and the infants’ sur-
vival rate was 71%.9 In addition, some successful single cases 
have been reported.10–12
The main technical problem expected with ECMO in preg-
nancy is difficult blood drainage because of caval compres-
sion by the gravid uterus: emergency delivery or placement of 
additional venous cannulas may be required.13 In our patient 
a femorojugular bypass was used, blood was drained through 
a femoral cannula of very large caliber (25 F), and the patient 
was kept in left lateral decubitus: this allowed the maintenance 
Figure 1. Chest x-ray at admission, showing diffuse, patchy infiltrates in both lungs. Arrows indicate the position of extracorporeal cannulas 
(in the upper left corner of the tip of the femoral cannula).
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of a high extracorporeal blood ﬂow without excessive negative 
suction pressures.
Patients on ECMO need to be systemically anticoagulated. 
Heparin has no effect on the fetus because it does not cross 
the placental barrier, whereas the risk of obstetric hemorrhagic 
complications is obviously increased.
The efficacy and safety of corticosteroids in patients with 
serious respiratory complications from H1N1 inﬂuenza is 
unclear.14 A recent study showed an improved outcome of a 
very small number of patients with ARDS from pandemic H1N1 
inﬂuenza receiving moderate doses of methylprednisolone.15 
Despite this, current WHO guidelines do not recommend 
adjuvant steroid administration (World Health Organization. 
Clinical management of human infection with new inﬂuenza 
A (H1N1) virus: initial guidance [http://www.emro.who.int/csr/
h1n1/pdf/clinical_management_21_5_2009.pdf]).
This issue is particularly interesting during pregnancy, when 
in situations of threatened preterm labor or emergency delivery 
a course of bethametasone or dexamethasone is administered 
to promote fetal maturity. Current evidence does not suggest 
a negative impact of this practice on the maternal immune 
system.16,17
When caring for a critically ill pregnant woman, the most 
challenging issue is the selection of the appropriate timing 
for delivery. Delivery is expected to improve maternal condi-
tion by reducing the metabolic and cardiovascular demand 
associated with pregnancy. In patients on ECMO, the delivery 
may have the additional benefit of facilitating blood drainage. 
In a review of 28 pregnant women with ARDS, Catanzarite et 
al.13 suggested that delivery is indicated during the third trimes-
ter of pregnancy or in case of deteriorating maternal conditions. 
Other authors caution against routine delivery, emphasizing 
that the risks associated with labor or cesarean delivery may be 
unacceptably high.18,19 In our patient, emergency delivery was 
considered immediately after admission, but no clear signs of 
fetal distress were evident while the risk of a surgical proce-
dure in such a critical patient was extremely high. For these 
reasons we found it more reasonable to postpone the delivery, 
considering ECMO support the best option to warrant the high-
est chance of survival to both the mother and the fetus. Thus, it 
is clear that this kind of decision is extremely challenging and 
has to be made on a case-by-case basis, in conjunction with 
the obstetric, neonatal, and critical care teams.
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